Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q1 FY27 Earnings Presentation
29 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Aug 10, 2026
Slide 1: Exchange filing cover letter for Q1FY27 investor presentation
YH/SE/37/2026-27 August 11, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai - 400001
Slide 2: Q1 FY27 Earnings Presentation
Q1 FY27 Earnings Presentation August 10, 2026
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements does not guarantee future performance and are subject
Slide 4: Financial Snapshot for Q1 FY27
Financial Snapshot for Q1 FY27 Record Revenue and EBITDA growth; EBITDA Margin (adjusted for ramp-up losses) stood robust 28.1% Revenue EBITDA EBITDA Margin – Adjusted EBITDA Margin PAT Consolidated Excl MT & Fbd Sec-20 1 Rs 3,927 mn Rs 917 mn Rs 454 mn 23.3% 28.1% +51% YoY | +15% QoQ +39% YoY | +15
Slide 5: Highlights for the Quarter
Highlights for the Quarter Faridabad Sec-20 New Delhi achieves Agra EBITDA Margin New Hospitals1 contribute Acquisition Playbook EBITDA ~50k >20% 27% to mix demonstrating success vs 22% in Q4 Breakeven ARPOB within 1st full in record 9 months alongside Noida Extension quarter Attract, retain and ali
Slide 6: Financial Performance
Financial Performance Record Revenue & EBITDA Growth; Faridabad Sector-20 achieves EBITDA breakeven Revenue (Rs mn) EBITDA (Rs mn) +51% YoY +39% YoY +15% QoQ 4,0 00 950 +15% QoQ 0.8 3,5 00 900 850 0.7 5 800 3,0 00 3,927 750 3,416 700 0.7 917 2,5 00 650 799 2,592 600 660 0.6 5 550 2,0 00 500 450 0.6
Slide 7: Operational Performance
Operational Performance Sustained Occupancy and ARPOB gains across the Network; Premium NCR Hospitals near Rs 50k ARPOB Bed Capacity & Occupancy1 (%) ARPOB (Rs) & ALOS (days) 50 49 000 900 5.5 5.48 9 49 49 800 700 5.478 5.46 7 49 49 600 500 5.45 5.44 5 6 49 49 400 30 0 5.434 5.423 49 20 490001000 5.
Slide 8: Faridabad Sec-20 achieves EBITDA breakeven in record 9 months
Faridabad Sec-20 achieves EBITDA breakeven in record 9 months Rapid scale-up and high-value mix drives path to profitability Bed Capacity Q1 FY27 Revenue 400 Beds Rs 33 crore (~9% share) Latest Monthly Revenue Latest ARPOB ~Rs 12-13 crore ~Rs 40K Business Mix >90% Cash / TPA Q1FY27 EBITDA BREAKEVEN
Slide 9: New Delhi Ramping up Strongly, with ARPOB approaching Rs50k mark
New Delhi Ramping up Strongly, with ARPOB approaching Rs50k mark Early performance validates acquisition strategy and premium patient mix from day 1 Bed Capacity Q1 FY27 Revenue Model Town, New Delhi 300 Beds Rs 19 crore (~5% share) Latest Monthly Revenue Latest ARPOB ~Rs 8 crore ~Rs 50K Business Mi
Slide 10: Agra Hospital achieves 20%+ EBITDA in 1st Full Quarter of Integration
Agra Hospital achieves 20%+ EBITDA in 1st Full Quarter of Integration Integration expands regional presence and enhances the NCR healthcare ecosystem Bed Capacity Q1 FY27 Revenue 250 Beds Rs 24 crore (~6% share) Latest Monthly Revenue ~Rs 9-10 crore Latest ARPOB ~Rs 30K+ Q1FY27 EBITDA >20% Agra’s 1s
Slide 11: The Upcoming Cluster, Gurugram
The Upcoming Cluster, Gurugram Under-construction 250-bedded hospital in a high opportunity premium catchment of NCR Under-Construction Ultra-modern Super-speciality Hospital Located Sector 40, Gurugram ARPOB Potential Proposed Bed Capacity 250 ~Rs 50k+ 100% Stake Acquisition Additional Outlay inclu
Slide 12: Diversifying Network Across NCR
Diversifying Network Across NCR New Hospitals Scaling Quickly, while Existing Assets Continue to Compound FY23 Q1 FY26 Q1 FY27 3% 7% 5% 6% 9% 25% 7% 26% 34% Journey 33% 8% Rs 5,203 mn Rs 2,592 mn Rs 3,927 mn 20% 9% 38% 24% 16% 30% Noida Extension Greater Noida Noida Faridabad Greater Faridabad Jhans
Slide 13: Achievements during the Quarter
Achievements during the Quarter RECOGNISED . RATED . TRUSTED “ Yatharth Super Speciality Hospitals dominated the Outlook Best Hospital Rankings 2026 “ AMONG THE BEST CARDIOLOGY & ONCOLOGY HOSPITALS AMONG THE BEST MULTISPECIALITY HOSPITALS AMONG THE BEST ORTHOPAEDICS & NEUROLOGY HOSPITALS AMONG THE B
Slide 14: Profit & Loss Summary
Profit & Loss Summary Change Change Particulars (Rs mn) Q1FY27 Q1FY26 Q4FY26 YoY QoQ Revenue from Operations 3,927 2,592 51.5% 3,416 14.9% Medical Consumables & Pharmacy 693 522 32.9% 622 11.5% Employee Expenses 779 482 61.7% 701 11.1% Other Expenses 1,537 929 65.4% 1,294 18.8% EBITDA 917 660 39.0%
Slide 15: About Yatharth
About Yatharth
Slide 16: Building North India's Trusted Healthcare Platform
Building North India's Trusted Healthcare Platform 9 2019 Noida Extension Hospitals* 2025 Model Town, Delhi 450 beds 300 beds 2013 Noida 12 2025 250 beds Faridabad 400 beds Centres of Excellence 2010 Greater Noida 2024 400 beds Gr. Faridabad 200 beds 2026 80% Agra 250 beds Beds in Metros* 2026 Gurug
Slide 17: Pursuing a Cluster-Based Growth Strategy for Expansion
Pursuing a Cluster-Based Growth Strategy for Expansion Building Density across clusters to drive Brand Recall and Market Leadership NEW DELHI Delhi NCR Entered with a 300 Bed Hospital Noida – Established Cluster ✓ 3 Hospitals, with 1,100 Beds (+450 Beds Underway) ✓ Largest player in Noida, with stro
Slide 18: Our Journey Since Listing in August 2023
Our Journey Since Listing in August 2023 9 HOSPITALS | 2,805 BEDS FASTEST 01 BED GROWTH 5 Hospitals added 1,400 Beds added 450 Beds Brownfield proposed at since Listing since Listing Noida Ext & Gr Noida REVENUE & PROFITABILITY GROWTH INDUSTRY LEADING 02 GROWTH Revenue CAGR 39% (FY21–26) 34% EBITDA
Slide 19: The Growth Flywheel
The Growth Flywheel HOW IT COMPOUNDS Capacity Expansion Rising Occupancy Greenfield and Capacity Rising Improving High-end Higher ARPOB On a maturing brownfield strategic Expansion Occupancy Payer Mix Specialities & Margin acquisitions base Cash funds Improving the next bed The Payer Mix Self-financ
Slide 20: 1. Clear Roadmap to Scale Capacity
1. Clear Roadmap to Scale Capacity Announced bed capacity expansion plan of ~3,250 beds; target ~5,000 bed capacity over next 3 Years Operational Beds New Beds Added Proposed Bed Addition Announced Capacity 5,500 5,000 4,500 Over next 24 months* 4,000 Operationalise by Q1 FY28 ~5,000 Beds Target 3,5
Slide 21: 2. Occupancy and Bed Commissioning to Drive Growth
2. Occupancy and Bed Commissioning to Drive Growth Significant headroom from occupancy ramp-up across mature hospitals and scaling of newer facilities BED CAPACITY ACROSS THE NETWORK Current Operational Census Yet to be Operational Census Non-Census Beds Additional Beds in Pipeline EXISTING HOSPITAL
Slide 22: 3. Diversifying Speciality Base across Hospitals
3. Diversifying Speciality Base across Hospitals Broader, high-value speciality base strengthening outcomes and profitability HIGH VALUE MIX DRIVING ARPOB EXPANSION Diverse mix of specialities at all hospitals Q1 FY2027 16% 12% 12% 9% 9% 8% 6% 6% 6% 5% 3% FY2026 19% 13% 10% 9% 9% FY2021 56% Internal
Slide 23: 4. Accelerating focus towards MVT opportunities, enhancing mix
4. Accelerating focus towards MVT opportunities, enhancing mix Exclusive hospital partner to Noida International Airport Global Brand Awareness Initiatives Exclusive Hospital Partnership to Jewar Airport • Expanded international footprint, with information Centre in Uzbekistan • Partnerships with he
Slide 24: 5. Mix Shift Lifts Group ARPOB
5. Mix Shift Lifts Group ARPOB Broader, high-value speciality base & payer mix at newer hospitals will strengthen ARPOB and profitability Enhanced WHERE THE MIX HAS SHIFTED (ARPOB Rs’ 000) share from higher ARPOB hospitals to drive ARPOB improvement with scale Sub-50k ARPOB Hospitals More than 50k A
Slide 25: Annexures
” ® i =) >< o c c <q
Slide 26: Proven Record of Consistent Financial Performance (1/2)
Proven Record of Consistent Financial Performance (1/2) Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 27.6% 25.7% 26.8% 25.4% 24.2% FY21-26 3500 3493 3486 28% 3479 3472 27% 3465 3458 3451 3444 26% 3437 3430 3423 3416 3409 25% 3402 3395 24% 3388 3381 3374 3367 23% 3360 3353 3346 3339 22% 3332 3325 3318 33
Slide 27: Proven Record of Consistent Financial Performance (2/2)
Proven Record of Consistent Financial Performance (2/2) RoCE (%) Net Worth (Rs mn) ROCE temporarily dipped 0.27 18,072 0.26 0.25 due to fund raise & capex 20,000.00 0.24 16,371 0.23 0.22 for acquisitions/ 0.21 0.2 29% infrastructure upgradations 0.19 15,000.00 28% 0.18 27% 0.17 0.16 0.15 8,743 0.14
Slide 28: Consistent Performance across Operational Parameters
Consistent Performance across Operational Parameters Bed Capacity & Occupancy (%) ARPOB (Rs) & ALOS (days) 80 % 3000 68% 61% 70% 5.2 4.3 4.8 4.3 4.2 2500 54% 50% 3400 0 5 60 % 33200 32400 31600 45% 3080 0 3000 0 29200 2840 0 276 00 2000 50 % 2680 0 2600 0 25200 0 2440 0 23600 22800 22000 33,124 40 %
Slide 29: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact Mr. Ashutosh Kumar Jha, Group Chief – Strategy, M&A and IR investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital & Trauma Care Services — Q1 FY27 Earnings Presentation on 6ix